JBM Healthcare Shares Plunge Over 12% Despite Annual Profit Growth

Stock News06-23

Shares of JBM HEALTHCARE (02161) experienced a sharp decline, dropping more than 12%. At the time of writing, the stock was down 12.28%, trading at HK$2.00 with a turnover of HK$4.1982 million.

The sell-off followed the release of the company's full-year results for the period ending March 31, 2026. The company reported revenue of approximately HK$835 million, representing a year-on-year increase of about 6.7%. Profit attributable to equity holders was around HK$201 million, marking a growth of approximately 1.9% compared to the previous year.

Earnings per share came in at 24.63 HK cents, with a proposed final dividend of 7.35 HK cents per share.

According to the company's announcement, the revenue growth was primarily driven by strong performance in the branded pharmaceuticals and branded traditional Chinese medicine segments. However, this positive contribution was partially offset by weaker performance in the health supplements division.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1125836943?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-06-23 11:58","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1125836943","market":"sg","top_or_hot":-1,"title":"JBM Healthcare Shares Plunge Over 12% Despite Annual Profit Growth","media":"Stock News","content":"<p>Shares of <b>JBM HEALTHCARE</b> (<b>02161</b>) experienced a sharp decline, dropping more than 12%. At the time of writing, the stock was down 12.28%, trading at HK$2.00 with a turnover of HK$4.1982 million.<br><br>The sell-off followed the release of the company's full-year results for the period ending March 31, 2026. The company reported revenue of approximately HK$835 million, representing a year-on-year increase of about 6.7%. Profit attributable to equity holders was around HK$201 million, marking a growth of approximately 1.9% compared to the previous year.<br><br>Earnings per share came in at 24.63 HK cents, with a proposed final dividend of 7.35 HK cents per share.<br><br>According to the company's announcement, the revenue growth was primarily driven by strong performance in the branded pharmaceuticals and branded traditional Chinese medicine segments. However, this positive contribution was partially offset by weaker performance in the health supplements division.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>JBM Healthcare Shares Plunge Over 12% Despite Annual Profit Growth</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nJBM Healthcare Shares Plunge Over 12% Despite Annual Profit Growth\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036600163\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock News </p>\n<p class=\"h-time\">2026-06-23 11:58</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Shares of <b>JBM HEALTHCARE</b> (<b>02161</b>) experienced a sharp decline, dropping more than 12%. At the time of writing, the stock was down 12.28%, trading at HK$2.00 with a turnover of HK$4.1982 million.<br><br>The sell-off followed the release of the company's full-year results for the period ending March 31, 2026. The company reported revenue of approximately HK$835 million, representing a year-on-year increase of about 6.7%. Profit attributable to equity holders was around HK$201 million, marking a growth of approximately 1.9% compared to the previous year.<br><br>Earnings per share came in at 24.63 HK cents, with a proposed final dividend of 7.35 HK cents per share.<br><br>According to the company's announcement, the revenue growth was primarily driven by strong performance in the branded pharmaceuticals and branded traditional Chinese medicine segments. However, this positive contribution was partially offset by weaker performance in the health supplements division.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4585","symbol_name":"ETF&股票定投概念","start_time":0,"source_url":"","article_id":"1125836943","we_media_id":"1036600163","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1125836943","pubTimestamp":1782187099,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Stock News","introduction":"Global Stock News First-Time Broadcast","home_visible":1,"id":"1036600163","head_image":"https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a"},"summary":"Shares of JBM HEALTHCARE (02161) experienced a sharp decline, dropping more than 12%. At the time of writing, the stock was down 12.28%, trading at HK$2.00 with a turnover of HK$4.1982 million.The...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4585":"ETF&股票定投概念","BK1606":"中医药概念","02161":"健倍苗苗","VXUS":"国际股票ETF-Vanguard","BK4588":"碎股","BK1191":"制药"},"translate_title":"尽管年度利润增长，JBM Healthcare股价仍暴跌超过12%","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"VXUS":1,"02161":1},"content_text":"Shares of JBM HEALTHCARE (02161) experienced a sharp decline, dropping more than 12%. At the time of writing, the stock was down 12.28%, trading at HK$2.00 with a turnover of HK$4.1982 million.The sell-off followed the release of the company's full-year results for the period ending March 31, 2026. The company reported revenue of approximately HK$835 million, representing a year-on-year increase of about 6.7%. Profit attributable to equity holders was around HK$201 million, marking a growth of approximately 1.9% compared to the previous year.Earnings per share came in at 24.63 HK cents, with a proposed final dividend of 7.35 HK cents per share.According to the company's announcement, the revenue growth was primarily driven by strong performance in the branded pharmaceuticals and branded traditional Chinese medicine segments. However, this positive contribution was partially offset by weaker performance in the health supplements division.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"-2","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.45.2","shortVersion":"4.45.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1125836943","isCrawlerRequest":true}